oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

LOREBLOK

Contamination with N-nitroso-N-methylamino butyric acid (NMBA) was detected in some batches of the losartan active substance (from Hetero Labs Limited). Potential effects: increased risk of carcinogenic effects with long-term exposure.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

LOREBLOK
Risk Level
Critical
Manufacturer
Orion Corporation z siedzibą w Finlandii
Recall Date
01.02.2019
View official statement

Important Information

What You Should Know

Recommendations

Do not use Loreblok or Loreblok HCT batches originating from Hetero Labs; return them to the pharmacy or distributor. If in doubt or if symptoms occur, contact a physician.

Actions Taken

Decision to withdraw and prohibit the marketing of batches containing losartan potassium from Hetero Labs; decision made immediately enforceable; obligation to take immediate actions in accordance wit...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Contamination with N-nitroso-N-methylamino butyric acid (NMBA) was detected in some batches of the losartan active substance (from Hetero Labs Limited). Potential effects: increased risk of carcinogenic effects with long-term exposure.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Check the official report for specific batch details.

Related

Other Recalled Products